Skip to main content
SpringerLink
Log in

Do You Have Any Risk Factors or Long-Term Health Conditions? How Environment, Lifestyle and Other Medical Conditions Are Linked to Kidney Disease

  • Chapter
  • First Online:
Understanding Kidney Diseases

  • 911 Accesses

Abstract

In this chapter we explain:

  • Environmental and lifestyle factors linked with kidney disease

  • How kidney disease develops in people with diabetes

  • How vascular disease can affect the kidneys

  • The hepatorenal syndrome

  • The effect of chronic infection and inflammation on the kidneys

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z. Particulate matter air pollution and the risk of incident CKD and progression to ESRD. J Am Soc Nephrol. 2018;29(1):218–30. https://doi.org/10.1681/ASN.2017030253. Epub 2017 Sep 21. https://jasn.asnjournals.org/content/jnephrol/29/1/218.full.pdf.

    Article  CAS  PubMed  Google Scholar 

  2. Lew QJ, Jafar TH, Koh HW, Jin A, Chow KY, Yuan JM, Koh WP. Red meat intake and risk of ESRD. J Am Soc Nephrol. 2017;28(1):304–12. https://doi.org/10.1681/ASN.2016030248. https://jasn.asnjournals.org/content/28/1/304.long.

    Article  PubMed  Google Scholar 

  3. Kelly JT, Palmer SC, Wai SN, Ruospo M, Carrero JJ, Campbell KL, Strippoli GF. Healthy dietary patterns and risk of mortality and ESRD in CKD: a meta-analysis of cohort studies. Clin J Am Soc Nephrol. 2017;12(2):272–9. https://doi.org/10.2215/CJN.06190616. Epub 2016 Dec 8. https://cjasn.asnjournals.org/content/12/2/272.long.

    Article  PubMed  Google Scholar 

  4. Bach KE, Kelly JT, Palmer SC, Khalesi S, Strippoli GFM, Campbell KL. Healthy dietary patterns and incidence of CKD—a meta-analysis of cohort studies. Clin J Am Soc Nephrol. 2019;14(10):1441–9. https://doi.org/10.2215/CJN.00530119. https://cjasn.asnjournals.org/content/early/2019/09/23/CJN.00530119.full.

    Article  CAS  PubMed  Google Scholar 

  5. Kim H, Caulfield LE, Garcia-Larsen V, Steffen LM, Grams ME, Coresh J, Rebholz CM. Plant-based diets and incident CKD and kidney function. Clin J Am Soc Nephrol. 2019;14(5):682–91. https://doi.org/10.2215/CJN.12391018. Epub 2019 Apr 25. https://cjasn.asnjournals.org/content/clinjasn/14/5/682.full.pdf.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Bigotte Vieira M, Magriço R, Viegas Dias C, Leitão L, Neves JS. Caffeine consumption and mortality in chronic kidney disease: a nationally representative analysis. Nephrol Dial Transplant. 2019;34(6):974–80. https://doi.org/10.1093/ndt/gfy234. https://academic.oup.com/ndt/article/34/6/974/5063554.

    Article  PubMed  Google Scholar 

  7. Hu EA, Selvin E, Grams ME, Steffen LM, Coresh J, Rebholz CM. Coffee consumption and incident kidney disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2018;72(2):214–22. https://doi.org/10.1053/j.ajkd.2018.01.030. https://www.ajkd.org/article/S0272-6386(18)30109-4/fulltext.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Rebholz CM, Grams ME, Steffen LM, Crews DC, Anderson CA, Bazzano LA, Coresh J, Appel LJ. Diet soda consumption and risk of incident end stage renal disease. Clin J Am Soc Nephrol. 2017;12(1):79–86. https://doi.org/10.2215/CJN.03390316. https://cjasn.asnjournals.org/content/12/1/79.long.

    Article  PubMed  Google Scholar 

  9. Ricardo AC, Knutson K, Chen J, Appel LJ, Bazzano L, Carmona-Powell E, Cohan J, Kurella Tamura M, Steigerwalt S, Thornton JD, Weir M, Turek NF, Rahman M, Van Cauter E, Lash JP, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. The association of sleep duration and quality with CKD progression. J Am Soc Nephrol. 2017;28(12):3708–15. https://doi.org/10.1681/ASN.2016121288. https://jasn.asnjournals.org/content/28/12/3708.long.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Sorensen C, Garcia-Trabanino R. A new era of climate medicine—addressing heat-triggered renal disease. N Engl J Med. 2019;381:693–6. https://doi.org/10.1056/NEJMp1907859. https://www.nejm.org/doi/full/10.1056/NEJMp1907859?query=TOC.

    Article  PubMed  Google Scholar 

  11. Raymond NT, Paul O’Hare J, Bellary S, Kumar S, Jones A, Barnett AH, UKADS Study Group. Comparative risk of microalbuminuria and proteinuria in UK residents of south Asian and white European ethnic background with type 2 diabetes: a report from UKADS. Curr Med Res Opin. 2011;27(Suppl 3):47–55. https://doi.org/10.1185/03007995.2011.614937. http://informahealthcare.com/doi/abs/10.1185/03007995.2011.614937.

    Article  CAS  PubMed  Google Scholar 

  12. Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease. Challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–45. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718284/.

    Article  CAS  Google Scholar 

  13. Molitch ME, Gao X, Bebu I, de Boer IH, Lachin J, Paterson A, Perkins B, Saenger AK, Steffes M, Zinman B, Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Early glomerular hyperfiltration and long-term kidney outcomes in Type 1 diabetes: the DCCT/EDIC experience. Clin J Am Soc Nephrol. 2019;14(6):854–61. https://doi.org/10.2215/CJN.14831218. https://cjasn.asnjournals.org/content/clinjasn/early/2019/05/22/CJN.14831218.full.pdf.

    Article  PubMed  Google Scholar 

  14. Tonneijck L, Muskiet MH, Smits MM, van Bommel EJ, Heerspink HJ, van Raalte DH, Joles JA. Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment. J Am Soc Nephrol. 2017;28(4):1023–39. https://doi.org/10.1681/ASN.2016060666. Epub 2017 Jan 31. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5373460/.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Tummalapalli SL, Shlipak MG. Hyperfiltration. Clin J Am Soc Nephrol. 2019. https://doi.org/10.2215/CJN.05330419. https://cjasn.asnjournals.org/content/clinjasn/early/2019/05/22/CJN.05330419.full.pdf.

  16. Skupien J, Warram JH, Smiles AM, Stanton RC, Krolewski AS. Patterns of estimated glomerular filtration rate decline leading to end-stage renal disease in Type 1 diabetes. Diabetes Care. 2016;39(12):2262–9. Epub 2016 Sep 19. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127236/.

    Article  CAS  Google Scholar 

  17. Krolewski AS, Skupien J, Rossing P, Warram JH. Fast renal decline to ESRD: an unrecognized feature of nephropathy in diabetes. Kidney Int. 2017;91(6):1300–11. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429989/.

    Article  Google Scholar 

  18. de Boer IH, DCCT/EDIC Research Group. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37(1):24–30. https://doi.org/10.2337/dc13-2113. http://care.diabetesjournals.org/content/37/1/24.full.

    Article  CAS  PubMed  Google Scholar 

  19. Salem RM, Todd JN, Sandholm N, et al. SUMMIT Consortium, DCCT/EDIC Research Group, GENIE Consortium. Genome-wide association study of diabetic kidney disease highlights biology involved in glomerular basement membrane collagen. J Am Soc Nephrol. 2019;30(10):2000–16. https://doi.org/10.1681/ASN.2019030218. https://jasn.asnjournals.org/content/jnephrol/early/2019/09/18/ASN.2019030218.full.pdf.

    Article  CAS  PubMed  Google Scholar 

  20. Coca SG, Ismail-Beigi F, Haq N, Krumholz HM, Parikh CR. Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes. Arch Intern Med. 2012;172(10):761–9. https://doi.org/10.1001/archinternmed.2011.2230. http://archinte.jamanetwork.com/article.aspx?articleid=1170041.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Wong MG, Perkovic V, Chalmers J, Woodward M, Li Q, Cooper ME, Hamet P, Harrap S, Heller S, MacMahon S, Mancia G, Marre M, Matthews D, Neal B, Poulter N, Rodgers A, Williams B, Zoungas S, ADVANCE-ON Collaborative Group. Long-term benefits of intensive glucose control for preventing end-stage kidney disease: ADVANCE-ON. Diabetes Care. 2016;39(5):694–700. https://doi.org/10.2337/dc15-2322. Epub 2016 Mar 22. http://care.diabetesjournals.org/content/39/5/694.long.

    Article  CAS  PubMed  Google Scholar 

  22. Mottl AK, Buse JB, Ismail-Beigi F, Sigal RJ, Pedley CF, Papademetriou V, Simmons DL, Katz L, Mychaleckyj JC, Craven TE. Long-term effects of intensive glycemic and blood pressure control and fenofibrate use on kidney outcomes. Clin J Am Soc Nephrol. 2018;13(11):1693–702. https://doi.org/10.2215/CJN.06200518. Epub 2018 Oct 25. https://cjasn.asnjournals.org/content/13/11/1693.long.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ruospo M, Saglimbene VM, Palmer SC, et al. Glucose targets for preventing diabetic kidney disease and its progression. Cochrane Database Syst Rev. 2017;6:CD010137. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010137.pub2/full.

    PubMed  Google Scholar 

  24. Reaven PD, Emanuele NV, Wiitala WL, Bahn GD, Reda DJ, McCarren M, Duckworth WC, Hayward RA, VADT Investigators. Intensive glucose control in patients with Type 2 diabetes—15-year follow-up. N Engl J Med. 2019;380(23):2215–24. https://doi.org/10.1056/NEJMoa1806802. https://www.nejm.org/doi/full/10.1056/NEJMoa1806802?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Papademetriou V, Lovato L, Doumas M, Nylen E, Mottl A, Cohen RM, Applegate WB, Puntakee Z, Yale JF, Cushman WC, ACCORD Study Group. Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes. Kidney Int. 2015;87:649–59. https://doi.org/10.1038/ki.2014.296. http://www.nature.com/ki/journal/v87/n3/full/ki2014296a.html.

    Article  PubMed  Google Scholar 

  26. Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, Williams DE, Geiss L. Changes in diabetes-related complications in the United States, 1990–2010. N Engl J Med. 2014;370:1514–23. https://doi.org/10.1056/NEJMoa1310799. http://www.nejm.org/doi/full/10.1056/NEJMx140023.

    Article  CAS  PubMed  Google Scholar 

  27. Andrésdóttir G, Jensen ML, Carstensen B, Parving HH, Hovind P, Hansen TW, Rossing P. Improved prognosis of diabetic nephropathy in type 1 diabetes. Kidney Int. 2015;87(2):417–26. https://doi.org/10.1038/ki.2014.206. http://www.nature.com/ki/journal/v87/n2/abs/ki2014206a.html.

    Article  CAS  PubMed  Google Scholar 

  28. Ingelfinger JR, Rosen CJ. Clinical credence—SGLT2 inhibitors, diabetes, and chronic kidney disease. N Engl J Med. 2019;380(24):2371–3. https://doi.org/10.1056/NEJMe1904740. https://www.nejm.org/doi/full/10.1056/NEJMe1904740?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed.

    Article  PubMed  Google Scholar 

  29. Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW, CREDENCE Trial Investigators. Canagliflozin and renal outcomes in Type 2 diabetes and nephropathy. N Engl J Med. 2019;380(24):2295–306. https://www.nejm.org/doi/full/10.1056/NEJMoa1811744.

    Article  CAS  Google Scholar 

  30. Jennings CG, Houston JG, Severn A, Bell S, Mackenzie IS, MacDonald TM. Renal artery stenosis—when to screen, what to stent? Curr Atheroscler Rep. 2014;16(6):416. https://doi.org/10.1007/s11883-014-0416-2. http://link.springer.com/article/10.1007/s11883-014-0416-2/fulltext.html.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Escárcega RO, Mathur M, Franco JJ, Alkhouli M, Patel C, Singh K, Bashir R, Patil P. Nonatherosclerotic obstructive vascular diseases of the mesenteric and renal arteries. Clin Cardiol. 2014;37(11):700–6. https://doi.org/10.1002/clc.22305. Epub 2014 Aug 6. http://onlinelibrary.wiley.com/doi/10.1002/clc.22305/pdf.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Francoz C, Durand F, Kahn JA, Genyk YS, Nadim MK. Hepatorenal syndrome. Clin J Am Soc Nephrol. 2019;14(5):774–81. https://doi.org/10.2215/CJN.12451018. https://cjasn.asnjournals.org/content/14/5/774.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Kupin WL. Viral-associated GN: hepatitis B and other viral infections. Clin J Am Soc Nephrol. 2017;12(9):1529–33. https://doi.org/10.2215/CJN.09180816. Epub 2016 Oct 18. https://cjasn.asnjournals.org/content/12/9/1529.long.

    Article  CAS  PubMed  Google Scholar 

  34. Kupin WL. Viral-associated GN: hepatitis C and HIV. Clin J Am Soc Nephrol. 2017;12(8):1337–42. https://doi.org/10.2215/CJN.04320416. Epub 2016 Oct 24. https://cjasn.asnjournals.org/content/12/8/1337.long.

    Article  CAS  PubMed  Google Scholar 

  35. Phair J, Palella F. Renal disease in HIV-infected individuals. Curr Opin HIV AIDS. 2011;6(4):285–9. https://doi.org/10.1097/COH.0b013e3283476bc3. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266688/.

    Article  PubMed  PubMed Central  Google Scholar 

  36. de Seigneux S, Lucas GM. Renal injury and human immunodeficiency virus: what remains after 30 years? Nephrol Dial Transplant. 2019:gfz162. https://doi.org/10.1093/ndt/gfz162. https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfz162/5549238.

Download references

Author information

Authors and Affiliations

  1. Birmingham Heartlands Hospital, Birmingham, UK

    Hugh C. Rayner & Mark E. Thomas

  2. Birmingham Children’s Hospital, Birmingham, UK

    David V. Milford

Authors
  1. Hugh C. Rayner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark E. Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David V. Milford
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rayner, H.C., Thomas, M.E., Milford, D.V. (2020). Do You Have Any Risk Factors or Long-Term Health Conditions? How Environment, Lifestyle and Other Medical Conditions Are Linked to Kidney Disease. In: Understanding Kidney Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-43027-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-43027-6_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-43026-9

  • Online ISBN: 978-3-030-43027-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation